Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Bilastine 20 mg vs BilaxTEN in Healthy Thai Volunteers (Fasting)
TCTR20220930005Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bilastine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by International Bio Service. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
bilastine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20220930005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220930005.